SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694665-23-000167
Filing Date
2023-11-03
Accepted
2023-11-03 16:11:13
Documents
1
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1699042256.html 4  
1 FORM 4 wk-form4_1699042256.xml 4 7734
  Complete submission text file 0001694665-23-000167.txt   9079
Mailing Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1226 CHARTER LANE AMBLER PA 19002
Business Address
Thorell Marella (Reporting) CIK: 0001826323 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 231376437